|Home | About | Journals | Submit | Contact Us | Français|
Robin Spiller, Fanny Pélerin, Amélie Cayzeele Decherf, Corinne Maudet, Béatrice Housez, Murielle Cazaubiel and Peter Jüsten. Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterology Journal 2016; 4: 353–362. doi: 10.1177/2050640615602571.
On page 357, in the section “Results on total population”, the abdominal pain/discomfort scores observed in both active and placebo groups have been inverted. This should read as:
“Considering abdominal pain/discomfort score, significant decrease was observed from the beginning to the end of supplementation, in both active and placebo groups (respectively, −0.61 and −0.43, p<0.0001 in both groups).”